AeroVironment, Inc. january 20, 2026 Please complete the form below to contact Kaplan Fox regarding the AeroVironment Investigation: Join a Case First Name * Last Name * Email Address * Phone Number * Ticker Symbol Or Company Name * Please Insert Your Estimation Of Losses In USD * Are you a current or former employee of the company mentioned having traded above? * Yes No Captcha Submit If you are human, leave this field blank. Principle Contacts Jeffrey P. Campisi JCampisi@kaplanfox.comLaurence D. KingLKing@kaplanfox.com Kaplan Fox Announces an Investigation into AeroVironment, Inc. (AVAV) for Potential Securities Law Violations Kaplan Fox & Kilsheimer LLP is investigating potential securities violations against AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV). CLICK HERE TO RECEIVE MORE INFORMATION ABOUT THIS INVESTIGATION If you are a AeroVironment investor and have suffered losses, or if you have information that could assist in the AeroVironment investigation, you may CLICK HERE to contact us. You may also contact Kaplan Fox by emailing jcampisi@kaplanfox.com or by calling (212) 329-8571. On January 20, 2026, before markets opened, the Company reported in an 8-K filing with the Securities and Exchange Commission that “upon mutual agreement” of AeroVironment and the U.S. Government, “the U.S. Government issued a stop work order on the Company’s Other Transaction Agreement for the delivery of BADGER phased array antenna systems to support the Satellite Communication Augmentation Resource (“SCAR”) program.” According to the filing, “[t]he stop work order allows for the parties to negotiate an amended agreement for the future of the SCAR program under new requirements for the program, which amendment is expected to be a firm-fixed price agreement. The Company expects to continue to deliver capabilities and products for the SCAR program.” Following this news, on January 20, 2026, the price of AeroVironment stock declined from a closing price on January 16, 2026 of $392.86 per share, to close at $330.89 per share, a decline of $61.97 per share, or by 15.77%. WHY CONTACT KAPLAN FOX Kaplan Fox is a leading national law firm focusing on complex litigation with offices in New York, Oakland, Los Angeles, Chicago and New Jersey. With over 50 years of experience in securities litigation, Kaplan Fox offers the professional experience and track record that clients demand. Through prosecuting cases on the federal and state levels, Kaplan Fox has successfully shaped the law through winning many important decisions on behalf of our clients. For more information about Kaplan Fox & Kilsheimer LLP, you may visit our website at www.kaplanfox.com. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules. If you have any questions about this Notice, your rights, or your interests, please contact: CONTACT:Jeffrey P. CampisiKAPLAN FOX & KILSHEIMER LLP800 Third Avenue, 38th FloorNew York, New York 10022(212) 329-8571jcampisi@kaplanfox.com Laurence D. KingKAPLAN FOX & KILSHEIMER LLP1999 Harrison Street, Suite 1501Oakland, California 94612(415) 772-4704lking@kaplanfox.com The submission of this form does not create an attorney-client relationship, nor an obligation on the part of Kaplan Fox to retain you as a client. Any information you submit will be maintained as confidential. If Kaplan Fox, in its sole discretion, believes that you might be an appropriate client, Kaplan Fox will contact you to discuss the matter and whether to establish an attorney client relationship. By signing this form you are authorizing us to contact you regarding this case and/or future cases. Connect with Kaplan Fox. Receive a complimentary case review now. Contact Us Wealthfront Corporation See the Case Chagee Holdings Limited See the Case AeroVironment, Inc. See the Case Aquestive Therapeutics, Inc. See the Case Snowflake Inc. See the Case Jefferies Financial Group See the Case Ardent Health, Inc. See the Case CoreWeave, Inc. See the Case Beta Bionics, Inc. See the Case Varonis Systems, Inc. See the Case Klarna Group PLC See the Case Quantum Biopharma Ltd. See the Case
